Search
healthcare › clinical-trials › h-49062
… multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter … with the Edwards Pascal Transcatheter valve repair system compared to abbott mitraclip in patients with mitral regurgitation. … A study to evaluate transcatheter mitral valve repair with the …
news › oops-after-ten-years-and-1000-studies-epigeneticists-uncover-trouble-in-their-tool-box
… established during development – can affect one’s risk of disease. For over a decade scientists have studied … College of Medicine reveals that the commercial tool that has been the workhorse for these studies is actually not … As a step toward this, the current study investigated how DNA methylation at CoRSIVs is affected by genetics. …
news › trish-to-study-spaceflight-effects-on-genome-and-nervous-system-on-axiom-spaces-ax-3-mission
… and performance research projects during Axiom Space’s upcoming Axiom Mission 3 (Ax-3) to the International Space Station (ISS), scheduled to … from NASA’s Kennedy Space Center in Florida. “Axiom Space appreciates the continued partnership with TRISH on our … TRISH to study spaceflight effects on genome and nervous system on …
news › dr-maria-elena-bottazzi-dr-teresa-a-davis-elected-to-the-national-academy-of-medicine
… Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine … Center at Baylor and Texas Children’s, have been elected to the National Academy of Medicine . They are among 90 … have demonstrated outstanding professional achievement and commitment to service. “Drs. Bottazzi and Davis are leaders …
healthcare › clinical-trials › h-55239
… Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major … The purpose of this study is to evaluate the safety, efficacy, and maintenance of effect …
news › breakthrough-in-human-norovirus-research-researchers-overcome-major-obstacle-to-grow-and-study-the-virus
… of acute viral gastroenteritis worldwide with severe outcomes mostly among young children, the elderly and people … or compromised immune systems. There are currently no approved vaccines or antiviral therapies, and management … has overcome a major obstacle that limited their ability to continuously grow virus, which they require to conduct …
healthcare › clinical-trials › h-53299
… is a next-generation small molecule cardiac myosin inhibitor being developed as a chronic, oral treatment for … hypertrophic cardiomyopathy (HCM). Aficamten is designed to reduce the hypercontractility that underlies the … and addressing the fundamental cause of this sarcomeric disease. This is the second Phase 3 trial of …
healthcare › clinical-trials › h-54042
… normal daily activities. SAGE-718 is a unique modulator (regulator of activity) of N-methyl-D-aspartate (NMDA) receptors. NMDA receptors are a type of protein with an important … A study of long-term safety and tolerability of Sage-718 in participants with Huntington's …
healthcare › clinical-trials › h-54088
… and safety of suvecaltamide in the treatment of moderate to severe residual tremor in participants with Parkinson's … The purpose of this study is to evaluate suvecaltamide in Parkinson’s disease … means that the Food and Drug Administration (FDA) has not approved it for the treatment of Parkinson’s disease or any …
healthcare › clinical-trials › h-56035
… This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …